Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₺46.629,67, with a 24-hour trading volume of ₺1,68B. The asset's market cap is ₺41,58T, after moving 0.33% in the last day.
Tokenized Eli Lilly And Co is trading at ₺46.767,11, with a tokenized market cap of ₺262,34M and a 24-hour trading volume of ₺96,84M. The tokenized asset has moved -0.01% in the past 24 hours.